From: Risk factors and negative consequences of patient’s delay for penile carcinoma
Variables | Overall survival, year (≥2 vs. <2) | Overall survival, year (≥5 vs. <5) | Relapses within 2 yearsa (none vs. relapsesb) | Relapses within 5 yearsa (none vs. relapsesb) | |||||
---|---|---|---|---|---|---|---|---|---|
OR (95 % CI) | p value | OR (95 % CI) | p value | OR (95 % CI) | p value | OR (95 % CI) | p value | ||
Undelayed (n = 63) | Reference | Reference | Undelayed (n = 63) | Reference | Reference | ||||
Delay 1–3 months (n = 64) | 0.984 (0.134–7.209) | 1.000e | 1.309 (0.456–3.762) | 0.616 | Delay 1–3 months (n = 62) | 0.803 (0.307–2.097) | 0.653 | 0.870 (0.395–1.914) | 0.728 |
Delay 3–6 months (n = 46) | 2.905 (0.509–16.587) | 0.238e | 1.684 (0.564–5.034) | 0.347 | Delay 3–6 months (n = 46) | 0.709 (0.242–2.081) | 0.530 | 0.694 (0.286–1.689) | 0.420 |
Delay >6 months (n = 55) | 5.191 (1.053–25.598) | 0.043e | 2.476 (0.909–6.746) | 0.070 | Delay >6 months (n = 54) | 0.945 (0.359–2.487) | 0.909 | 0.714 (0.307–1.659) | 0.433 |